- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cytokine release syndrome: grading, modeling, and new therapy ; volume:11 ; number:1 ; day:24 ; month:9 ; year:2018 ; pages:1-7 ; date:12.2018
Journal of hematology & oncology ; 11, Heft 1 (24.9.2018), 1-7, 12.2018
- Urheber
-
Liu, Delong
- Beteiligte Personen und Organisationen
-
Zhao, Juanjuan
SpringerLink (Online service)
- DOI
-
10.1186/s13045-018-0653-x
- URN
-
urn:nbn:de:101:1-2018110721470752878801
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Delong
- Zhao, Juanjuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine release syndrome
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Cytokine release syndrome
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Cytokine release syndrome
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after radiation therapy: case report and review of the literature
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy